BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38158099)

  • 1. Danggui Buxue Tang improves therapeutic efficacy of doxorubicin in triple negative breast cancer via ferroptosis.
    Gong G; Ganesan K; Liu Y; Huang Y; Luo Y; Wang X; Zhang Z; Zheng Y
    J Ethnopharmacol; 2024 Apr; 323():117655. PubMed ID: 38158099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
    Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
    Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ononin triggers ferroptosis-mediated disruption in the triple negative breast cancer both in vitro and in vivo.
    Gong G; Wan Y; Liu Y; Zhang Z; Zheng Y
    Int Immunopharmacol; 2024 May; 132():111959. PubMed ID: 38554442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Danggui Buxue Tang promotes the adhesion and migration of bone marrow stromal cells via the focal adhesion pathway in vitro.
    Bo H; He J; Wang X; Du R; Bei H; Chen J; Wang J; Wu F; Zhang W; Chen Q
    J Ethnopharmacol; 2019 Mar; 231():90-97. PubMed ID: 30445110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells.
    Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR
    BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells.
    Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W
    Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Stellera chamaejasme against multidrug resistance of triple-negative breast cancer MDA-MB-231 cell through Nrf2].
    Zeng R; Wang XX; Cui XH; Yang Q; Zhu XX; Wang YJ
    Zhongguo Zhong Yao Za Zhi; 2024 Apr; 49(8):2222-2229. PubMed ID: 38812237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LuQi formula attenuates Cardiomyocyte ferroptosis via activating Nrf2/GPX4 signaling axis in heart failure.
    Cheng P; Wang X; Liu Q; Yang T; Dai E; Sha W; Qu H; Zhou H
    Phytomedicine; 2024 Mar; 125():155357. PubMed ID: 38295662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ferroptosis-enhanced chemotherapy for triple-negative breast cancer with magnetic composite nanoparticles.
    Zhang J; Zhou K; Lin J; Yao X; Ju D; Zeng X; Pang Z; Yang W
    Biomaterials; 2023 Dec; 303():122395. PubMed ID: 37988899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propofol Inhibits Proliferation and Augments the Anti-Tumor Effect of Doxorubicin and Paclitaxel Partly Through Promoting Ferroptosis in Triple-Negative Breast Cancer Cells.
    Sun C; Liu P; Pei L; Zhao M; Huang Y
    Front Oncol; 2022; 12():837974. PubMed ID: 35419287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maresin-1 inhibits high glucose induced ferroptosis in ARPE-19 cells by activating the Nrf2/HO-1/GPX4 pathway.
    Li Y; Liu J; Ma X; Bai X
    BMC Ophthalmol; 2023 Sep; 23(1):368. PubMed ID: 37674121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota affects the efficacy of Danggui Buxue Tang by affecting plasma concentration of active ingredients.
    Chen J; Du R; Huang C; Jia L; Tie D; Fan Z; Zhou C; Chen Q; Bo H
    J Ethnopharmacol; 2021 Apr; 270():113835. PubMed ID: 33465445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rhein attenuates cerebral ischemia-reperfusion injury via inhibition of ferroptosis through NRF2/SLC7A11/GPX4 pathway.
    Liu H; Zhang TA; Zhang WY; Huang SR; Hu Y; Sun J
    Exp Neurol; 2023 Nov; 369():114541. PubMed ID: 37714424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Yi-qi-hua-yu-jie-du decoction induces ferroptosis in cisplatin-resistant gastric cancer via the AKT/GSK3β/NRF2/GPX4 axis.
    Huang W; Wen F; Yang P; Li Y; Li Q; Shu P
    Phytomedicine; 2024 Jan; 123():155220. PubMed ID: 38056149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nano-inducer of ferroptosis for targeted chemotherapy of human triple negative breast carcinoma.
    Shetake NG; Das SK; Kumar A; Pandey BN
    Biomater Adv; 2024 Jul; 161():213868. PubMed ID: 38677038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
    Zhou DD; Bai WQ; Zhai XT; Sun LP; Zhen YS; Li ZR; Miao QF
    Mil Med Res; 2021 Dec; 8(1):63. PubMed ID: 34879870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis.
    Wen RJ; Dong X; Zhuang HW; Pang FX; Ding SC; Li N; Mai YX; Zhou ST; Wang JY; Zhang JF
    Phytomedicine; 2023 Jul; 116():154881. PubMed ID: 37209607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis.
    Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxorubicin-Loaded Platelet Decoys for Enhanced Chemoimmunotherapy Against Triple-Negative Breast Cancer in Mice Model.
    Dong H; Gao M; Lu L; Gui R; Fu Y
    Int J Nanomedicine; 2023; 18():3577-3593. PubMed ID: 37409026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
    Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
    Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.